Anti-hTNF-α-hIgG1 Unit size Cat. code Docs Qty Price
100 µg

Neutralizing human IgG1 monoclonal antibody against human TNF-α

Anti-hTNF-α-hIgG1 is a neutralizing monoclonal antibody featuring the constant region of the human IgG1 isotype and the variable region of adalimumab. Adalimumab is a fully human monoclonal antibody against the pro-inflammatory cytokine human tumor necrosis factor alpha (hTNF-α). Adalimumab binds to TNF-α and blocks its interaction with TNF receptors thereby downregulating the inflammatory reactions associated with autoimmune diseases, such as rheumatoid arthritis and Crohn’s disease. Anti-hTNF-α-hIgG1 was generated by recombinant DNA technology. It has been produced in CHO cells and purified by affinity chromatography with protein G. The neutralizing activity of this human IgG1 antibody was determined using HEK-Blue™ TNF-α/IL-1β cells.

Back to the top


Clonality: Monoclonal antibody
Application: Neutralization of human TNF-α-induced cellular activation
Specificity: Human TNF-α
Isotype: Human IgG1

Back to the top


100 µg purified anti-hTNFα-hIgG1 antibody, provided azide-free and lyophilized

Back to the top

Customer Service
& Technical Support

In order to prevent automated spam submissions, please answer the following question:
1 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Shopping cart is empty